KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biomarin Pharmaceutical (BMRN) Debt Ratio: 2009-2024

Historic Debt Ratio for Biomarin Pharmaceutical (BMRN) over the last 10 years, with Jun 2024 value amounting to 0.07.

  • Biomarin Pharmaceutical's Debt Ratio was N/A to 0.07 in Q2 2024 from the same period last year, while for Jun 2024 it was 0.07, marking a year-over-year change of. This contributed to the annual value of 0.07 for FY2023, which is 2789.79% up from last year.
  • Per Biomarin Pharmaceutical's latest filing, its Debt Ratio stood at 0.07 for Q2 2024, which was down 2.66% from 0.07 recorded in Q1 2024.
  • In the past 5 years, Biomarin Pharmaceutical's Debt Ratio ranged from a high of 0.08 in Q1 2020 and a low of 0.00 during Q4 2022.
  • Its 3-year average for Debt Ratio is 0.04, with a median of 0.04 in 2022.
  • In the last 5 years, Biomarin Pharmaceutical's Debt Ratio spiked by 2,989.55% in 2020 and then crashed by 93.15% in 2021.
  • Biomarin Pharmaceutical's Debt Ratio (Quarterly) stood at 0.06 in 2020, then crashed by 86.73% to 0.01 in 2021, then plummeted by 68.90% to 0.00 in 2022, then surged by 2,789.79% to 0.07 in 2023, then reached 0.07 in 2024.
  • Its last three reported values are 0.07 in Q2 2024, 0.07 for Q1 2024, and 0.07 during Q4 2023.